-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PUyxFJgQCLZ0WHY8+jrYeAafsfyuPHsulFtSHTcNzH0m/0FFiLuLRzS6yrx44VR7 Y1iBRynbfIkvv2lL4gqmzg== 0001188112-10-000483.txt : 20100308 0001188112-10-000483.hdr.sgml : 20100308 20100308061259 ACCESSION NUMBER: 0001188112-10-000483 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20100308 DATE AS OF CHANGE: 20100308 GROUP MEMBERS: DANIEL J. DONOGHUE GROUP MEMBERS: DISCOVERY GROUP I, LLC GROUP MEMBERS: MICHAEL MURPHY SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CARDIONET INC CENTRAL INDEX KEY: 0001113784 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330604557 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-84428 FILM NUMBER: 10662265 BUSINESS ADDRESS: STREET 1: 1010 SECOND AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92101 BUSINESS PHONE: (619) 243-7500 MAIL ADDRESS: STREET 1: 1010 SECOND AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92101 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DISCOVERY EQUITY PARTNERS, LP CENTRAL INDEX KEY: 0001258542 IRS NUMBER: 300075082 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: C/O DISCOVERY GROUP I, LLC STREET 2: 191 N. WACKER DRIVE SUITE 1685 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-265-9600 MAIL ADDRESS: STREET 1: C/O DISCOVERY GROUP I, LLC STREET 2: 191 N. WACKER DRIVE SUITE 1685 CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: DISCOVERY EQUITY PARTNERS LP DATE OF NAME CHANGE: 20030806 SC 13D 1 t67336_sc13d.htm SC 13D t67336_sc13d.htm



 
UNITED STATES
OMB APPROVAL
 
SECURITIES AND EXCHANGE
COMMISSION
OMB Number:
3235-0145
 
Washington, D.C. 20549
Expires: February 28, 2009
 
SCHEDULE 13D
Estimated average burden hours per response. . 14.5
 
 
Under the Securities Exchange Act of 1934
(Amendment No. )*
 
CardioNet, Inc.
(Name of Issuer)
 
Common Stock, par value $0.001 per share
(Title of Class of Securities)
 
14159L103
(CUSIP Number)
 
Michael R. Murphy
Discovery Group I, LLC
191 North Wacker Drive
Suite 1685
Chicago, Illinois 60606
Telephone Number: (312) 265-9600
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
 
February 24, 2010
(Date of Event which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No.  14159L103
 
 
1.
Names of Reporting Persons.
Discovery Equity Partners, L.P.
 
 
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
   
(a)
 o
   
(b)
 o
 
 
3.
SEC Use Only
 
 
4.
Source of Funds (See Instructions)
WC
 
 
5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
 
 
6.
Citizenship or Place of Organization
Illinois
 
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7.
Sole Voting Power
None.
 
8.
Shared Voting Power
1,211,793
 
9.
Sole Dispositive Power
None.
 
10.
Shared Dispositive Power
1,211,793
 
 
11.
Aggregate Amount Beneficially Owned by Each Reporting Person
1,211,793
 
 
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
 
 
13.
Percent of Class Represented by Amount in Row (11)
5.1%
 
 
14.
Type of Reporting Person (See Instructions)
PN
 


CUSIP No.  14159L103
 
 
1.
Names of Reporting Persons.
Discovery Group I, LLC
 
 
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
   
(a)
 o
   
(b)
 o
 
 
3.
SEC Use Only
 
 
4.
Source of Funds (See Instructions)
AF
 
 
5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
 
 
6.
Citizenship or Place of Organization
Delaware
 
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7.
Sole Voting Power
None.
 
8.
Shared Voting Power
1,421,044
 
9.
Sole Dispositive Power
None.
 
10.
Shared Dispositive Power
1,421,044
 
 
11.
Aggregate Amount Beneficially Owned by Each Reporting Person
1,421,044
 
 
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
 
 
13.
Percent of Class Represented by Amount in Row (11)
5.9%
 
 
14.
Type of Reporting Person (See Instructions)
OO
 
 

CUSIP No.  14159L103
 
 
1.
Names of Reporting Persons.
Daniel J. Donoghue
 
 
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
   
(a)
 o
   
(b)
 o
 
 
3.
SEC Use Only
 
 
4.
Source of Funds (See Instructions)
AF
 
 
5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
 
 
6.
Citizenship or Place of Organization
United States of America
 
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7.
Sole Voting Power
None.
 
8.
Shared Voting Power
1,421,044
 
9.
Sole Dispositive Power
None.
 
10.
Shared Dispositive Power
1,421,044
 
 
11.
Aggregate Amount Beneficially Owned by Each Reporting Person
1,421,044
 
 
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
 
 
13.
Percent of Class Represented by Amount in Row (11)
5.9%
 
 
14.
Type of Reporting Person (See Instructions)
IN
 

CUSIP No.  14159L103
 
 
1.
Names of Reporting Persons.
Michael R. Murphy
 
 
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
   
(a)
 o
   
(b)
 o
 
 
3.
SEC Use Only
 
 
4.
Source of Funds (See Instructions)
AF
 
 
5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
 
 
6.
Citizenship or Place of Organization
United States of America
 
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
7.
Sole Voting Power
None.
 
8.
Shared Voting Power
1,421,044
 
9.
Sole Dispositive Power
None.
 
10.
Shared Dispositive Power
1,421,044
 
 
11.
Aggregate Amount Beneficially Owned by Each Reporting Person
1,421,044
 
 
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
 
 
13.
Percent of Class Represented by Amount in Row (11)
5.9%
 
 
14.
Type of Reporting Person (See Instructions)
IN
 

 
Item 1.
Security and Issuer
 
     
 
This statement relates to the Common Stock, $0.001 par value per share (the “Common Stock”), of CardioNet, Inc., a Delaware corporation (the “Company”), which has its principal executive offices at 227 Washington Street, Conshohocken, Pennsylvania 19428.
     
Item 2.
Identity and Background  
     
 
This statement is being jointly filed by the following persons (the “Reporting Persons”):

Discovery Equity Partners, L.P. (“Discovery Equity Partners”) is an Illinois limited partnership primarily engaged in the business of investing in securities.

Discovery Group I, LLC (“Discovery Group”) is a Delaware limited liability company primarily engaged in the business of investing in securities.

Daniel J. Donoghue is a Managing Member of Discovery Group and of various related entities, which is his principal occupation.

Michael R. Murphy is a Managing Member of Discovery Group and of various related entities, which is his principal occupation.

Both Mr. Donoghue and Mr. Murphy are United States citizens.

The business address of each of the Reporting Persons is 191 North Wacker Drive, Suite 1685, Chicago, Illinois 60606.
 
     
 
During the past five years, none of the Reporting Persons have been (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or finding any violation with respect to such laws.
 
     
Item 3.
Source and Amount of Funds or Other Consideration
 
     
 
The total purchase price for the 1,421,044 shares of Common Stock beneficially owned by Discovery Group and Messrs. Donoghue and Murphy as of March 5, 2010 was approximately $8,539,655, and the total purchase price for the 1,211,793 shares of Common Stock beneficially owned by Discovery Equity Partners was approximately $7,281,185.  The source of such funds was the assets of Discovery Equity Partners and another private investment partnership (collectively, the “Partnerships”) over which Discovery Group exercises discretionary investment management authority, including proceeds of margin loans under margin loan facilities maintained in the ordinary course of business by the Partnerships with a broker on customary terms and conditions.  The Partnerships are the legal owner of all of the Common Stock beneficially owned by Discovery Group and Messrs. Donoghue and Murphy.
 

 
Item 4. Purpose of Transaction  
     
The Reporting Persons acquired beneficial ownership of the shares of Common Stock reported herein as part of their investment activities on behalf of the Partnerships.  The Reporting Persons acquired the shares of Common Stock reported herein because they believe that the trading prices of the Common Stock do not adequately reflect the potential value of the Company’s underlying business and assets.
 
The Reporting Persons intend to review and evaluate their investment in the Common Stock on an ongoing basis and may, depending upon their evaluation of the business and prospects of the Company, or such other considerations as they may deem relevant, determine to increase, decrease, or dispose of their holdings of Common Stock.  As a part of such review and evaluation, the Reporting Persons may hold additional discussions with the Company’s management and directors, other shareholders and other interested parties.
 
Except as otherwise described in this Item 4, the Reporting Persons do not have present plans or proposals that relate to or would result in any of the following (although the Reporting Persons reserve the right to develop such plans or proposals or any other plans relating to the Company and to take action with respect thereto):  (i) the acquisition by any person of additional securities of the Company, or the disposition of securities of the Company; (ii) an extraordinary corporate transaction, such as a merger, reorganization, or liquidation, involving the Company or any of its subsidiaries; (iii) a sale or transfer of a material amount of assets of the Company or any of its subsidiaries; (iv) any change in the present board of directors or management of the Company, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (v) any material change in the present capitalization or dividend policy of the Company; (vi) any other material change in the Company’s business or corporate structure; (vii) changes in the Company’s certificate of incorporation, bylaws, or instruments corresponding thereto or other actions that may impede the acquisition of control of the Company by any person; (viii) causing a class of securities of the Company to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (ix) a class of equity securities of the Company becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934, as amended; or (x) any action similar to any of those enumerated above.
 
     
Item 5.
Interests in the Securities of the Issuer
 
   
 
The information concerning percentages of ownership set forth below is based on 23,961,921 shares of Common Stock reported outstanding as of February 10, 2010 in the Company’s most recent Annual Report on Form 10-K, for the period ended December 31, 2009.
 
Discovery Equity Partners beneficially owns 1,211,793 shares of Common Stock as of March 5, 2010, which represents 5.1% of the outstanding Common Stock.

Discovery Group beneficially owns 1,421,044 shares of Common Stock as of March 5, 2010, which represents 5.9% of the outstanding Common Stock.

Mr. Donoghue beneficially owns 1,421,044 shares of Common Stock as of March 5, 2010, which represents 5.9% of the outstanding Common Stock.
 

 
 
Mr. Murphy beneficially owns 1,421,044 shares of Common Stock as of March 5, 2010, which represents 5.9% of the outstanding Common Stock.

Discovery Group is the sole general partner of Discovery Equity Partners and has sole discretionary investment authority with respect to the other Partnership’s investment in the Common Stock.  Messrs. Donoghue and Murphy are the sole managing members of Discovery Group.  As a consequence, Discovery Group and Messrs. Donoghue and Murphy may be deemed to share beneficial ownership of all of the shares of Common Stock owned by both of the Partnerships, while Discovery Equity Partners shares beneficial ownership with Discovery Group and Messrs. Donoghue and Murphy of only the shares of Common Stock owned by it.
 
 
 
 
 
The transactions in Common Stock effected by the Reporting Persons during the past 60 days are set out in Exhibit 1 hereto.
 
No person other than the Partnerships is known to any Reporting Person to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any of the shares of Common Stock reported herein.
 
     
Item 6.
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
 
     
 
There are no contracts, arrangements, understandings or relationships (legal or otherwise) between or among any of the Reporting Persons and any other person with respect to any securities of the Company other than the governing documents of Discovery Group and the Partnerships, the margin loan facilities referred to under Item 3 above, the Joint Filing Agreement of the Reporting Persons with respect to this Schedule 13D included as Exhibit 2 to this Schedule 13D, and the Powers of Attorney granted by Messrs Donoghue and Murphy with respect to reports under Section 13 of the Securities Exchange Act of 1934, as amended, which Powers of Attorney are included as Exhibit 3 and Exhibit 4, respectively, to this Schedule 13D.
 
Item 7.
Material to Be Filed as Exhibits
 
     
 
Exhibit 1:               List of transactions by Reporting Persons in the Company’s Common Stock during the 60-day period preceding this filing.
 
     
 
Exhibit 2:               Joint Filing Agreement dated as of March 5, 2010, by and among Discovery Equity Partners; Discovery Group; Daniel J. Donoghue; and Michael R. Murphy.
 
     
 
Exhibit 3:               Power of Attorney of Daniel J. Donoghue, dated as of April 28, 2008.
 
     
 
Exhibit 4:               Power of Attorney of Michael R. Murphy, dated as of April 28, 2008.
 
 

Signature
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
March 5, 2010
 
 
Date
 
 
 
DISCOVERY GROUP I, LLC,
 
By:  Michael R. Murphy*
 
 
Signature
 
 
 
Michael R. Murphy, Managing Member
 
 
Name/Title
 
     
 
 
Daniel J. Donoghue*
 
 
Signature
 
 
 
Daniel J. Donoghue
 
 
Name/Title
 
     
 
 
Michael R. Murphy*
 
 
Signature
 
 
 
Michael R. Murphy
 
 
Name/Title
 
     
     
 
*By: /s/ Mark Buckley
 
 
Mark Buckley
Attorney-in-Fact for Daniel J. Donoghue
Attorney-in-Fact for Michael R. Murphy
 
     
 

Exhibit Index

 
Exhibit 1
 
List of transactions by Reporting Persons in the Company’s Common Stock during the 60-day period preceding this filing.
       
 
Exhibit 2
 
Joint Filing Agreement dated as of March 5, 2010, by and among Discovery Equity Partners; Discovery Group; Daniel J. Donoghue; and Michael R. Murphy.
       
 
Exhibit 3
 
Power of Attorney of Daniel J. Donoghue, dated as of April 28, 2008.
       
 
Exhibit 4
 
Power of Attorney of Michael R. Murphy, dated as of April 28, 2008.
 
EX-1 2 ex1.htm EXHIBIT 1 ex1.htm
EXHIBIT 1
 
TRANSACTIONS DURING PAST 60 DAYS

 
 
 

The Reporting Persons engaged in the following transactions in shares of Common Stock of the Company during the past 60 days.  Such transactions involved the purchase of shares on the Nasdaq National Market System.  The prices reported below reflect the weighted average purchase price of the shares of Common Stock purchased on the relevant date.  The Reporting Persons hereby undertake to provide upon request to the SEC staff full information regarding the number of shares and prices at which each transaction was effected.

 
Date
 
Type
 
Price
 
Shares
 
 
1/13/2010
 
Purchase
 
$6.00
 
5000
 
 
1/19/20101
 
Purchase
 
6.4504
 
52868
 
 
1/20/20102
 
Purchase
 
6.4987
 
5543
 
 
1/21/2010
 
Purchase
 
6.50
 
24437
 
 
1/22/20103
 
Purchase
 
6.4113
 
100000
 
 
1/25/20104
 
Purchase
 
6.489
 
32200
 
 
1/26/20105
 
Purchase
 
6.481
 
103648
 
 
1/27/20106
 
Purchase
 
6.3521
 
24000
 
 
1/28/20107
 
Purchase
 
6.1075
 
41700
 
 
1/29/20108
 
Purchase
 
6.0738
 
84315
 
 
2/01/20109
 
Purchase
 
5.9609
 
62532
 
 
2/02/201010
 
Purchase
 
5.9014
 
85410
 
 
2/03/201011
 
Purchase
 
5.8518
 
68523
 
 
2/04/201012
 
Purchase
 
5.6318
 
78600
 
 
2/5/201013
 
Purchase
 
5.5746
 
80664
 
 
2/8/201014
 
Purchase
 
5.6899
 
30613
 
 
 

 
_______________________________________ 
1 This transaction was executed in multiple trades at prices ranging from $6.35 - 6.50.
 

 
 
Date
 
Type
 
Price
 
Shares
 
 
2/9/201015
 
Purchase
 
$5.6837
 
30598
 
 
2/10/201016
 
Purchase
 
5.6668
 
40000
 
 
2/11/201017
 
Purchase
 
5.6251
 
23700
 
 
02/12/201018
 
Purchase
 
5.4993
 
43174
 
 
2/16/201019
 
Purchase
 
5.581
 
51000
 
 
2/17/201020
 
Purchase
 
5.5653
 
30000
 
 
2/23/201021
 
Purchase
 
5.7392
 
68894
 
 
2/24/201022
 
Purchase
 
5.8007
 
41501
 
 
2/25/201023
 
Purchase
 
5.8335
 
37141
 
 
2/26/201024
 
Purchase
 
5.9952
 
29242
 
 
3/01/201025
 
Purchase
 
5.9898
 
31900
 
 
3/02/2010
 
Purchase
 
5.95
 
2500
 
 
3/03/201026
 
Purchase
 
6.4851
 
76951
 
 
3/4/201027
 
Purchase
 
6.4421
 
34390
 
 
 
 
 
 
 
_______________________________________ 
15 This transaction was executed in multiple trades at prices ranging from $5.55 - 5.72.
16 This transaction was executed in multiple trades at prices ranging from $5.64 - 5.74.
17 This transaction was executed in multiple trades at prices ranging from $5.60 - 5.65.
18 This transaction was executed in multiple trades at prices ranging from $5.47 - 5.59.
19 This transaction was executed in multiple trades at prices ranging from $5.47 - 5.70.
20 This transaction was executed in multiple trades at prices ranging from $5.51 - 5.60.
21 This transaction was executed in multiple trades at prices ranging from $5.72 - 5.77.
22 This transaction was executed in multiple trades at prices ranging from $5.79 - 5.81.
23 This transaction was executed in multiple trades at prices ranging from $5.73 - 5.92.
24 This transaction was executed in multiple trades at prices ranging from $5.88 - 6.00.
25 This transaction was executed in multiple trades at prices ranging from $5.97 - 6.00.
26 This transaction was executed in multiple trades at prices ranging from $6.46 - 6.50.
27 This transaction was executed in multiple trades at prices ranging from $6.33 - 6.50.
EX-2 3 ex2.htm EXHIBIT 2 ex2.htm

EXHIBIT 2
 
JOINT FILING AGREEMENT

    The undersigned hereby agree to the joint filing of the Schedule 13D to which this Agreement is attached.
 
Dated:  March 5, 2010
 
 
DISCOVERY GROUP I, LLC
 
 
for itself and as general partner of
 
 
DISCOVERY EQUITY PARTNERS, L.P.
 
       
 
By
Michael R. Murphy*
 
   
Michael R. Murphy
 
   
Managing Member
 
       
       
  Daniel J. Donoghue*  
  Daniel J. Donoghue  
       
  Michael R. Murphy*  
  Michael R. Murphy  
       
       
       
 
*By:
/s/ Mark Buckley
 
   
Mark Buckley
 
   
Attorney-in-Fact for Daniel J. Donoghue
   
Attorney-in-Fact for Michael R. Murphy
 
EX-3 4 ex3.htm EXHIBIT 3 ex3.htm

EXHIBIT 3
 
POWER OF ATTORNEY
 
The undersigned, Daniel J. Donoghue, hereby appoints Mark Buckley his true and lawful attorney-in-fact and agent, with full power to execute and file with the United States Securities and Exchange Commission and any stock exchange or similar authority, for and on his behalf in any and all capacities, any and all reports required to be filed pursuant to Section 13 of the Securities Exchange Act of 1934 and the rules thereunder on Schedule 13D or 13G, any and all amendments to such reports, with all exhibits, and any other forms or documents as may be necessary in connection with the filing of such reports with the United States Securities and Exchange Commission and any stock exchange or similar authority, granting unto said attorney full power and authority to do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete, as fully as the undersigned might or could do in person.
 
This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact and agent.
 
IN WITNESS WHEREOF the undersigned has caused this Power of Attorney to be executed this 28th day of April, 2008.
 
 
 
 
/s/ Daniel J. Donoghue
 
 
Daniel J. Donoghue
 
 
 
 
STATE OF ILLINOIS
)
 
) SS.
COUNTY OF COOK
)
 
I, Kareema M. Cruz, a Notary Public in and for the County of Cook, State of Illinois, DO HEREBY CERTIFY that Daniel J. Donoghue, who is personally known to me to be the same person whose name is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he signed and delivered the said instrument as his own free and voluntary act, for the uses and purposes therein set forth.
 
Given under my hand and notarial seal, this 28th day of April, 2008.
 
 
/s/ Kareema M. Cruz
 
 
Notary Public
 
EX-4 5 ex4.htm EXHIBIT 4 ex4.htm

EXHIBIT 4
 
POWER OF ATTORNEY
 
The undersigned, Michael R. Murphy, hereby appoints Mark Buckley his true and lawful attorney-in-fact and agent, with full power to execute and file with the United States Securities and Exchange Commission and any stock exchange or similar authority, for and on his behalf in any and all capacities, any and all reports required to be filed pursuant to Section 13 of the Securities Exchange Act of 1934 and the rules thereunder on Schedule 13D or 13G, any and all amendments to such reports, with all exhibits, and any other forms or documents as may be necessary in connection with the filing of such reports with the United States Securities and Exchange Commission and any stock exchange or similar authority, granting unto said attorney full power and authority to do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete, as fully as the undersigned might or could do in person.
 
This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact and agent.
 
IN WITNESS WHEREOF the undersigned has caused this Power of Attorney to be executed this 28th day of April, 2008.
 
 
 
 
/s/ Michael R. Murphy
 
 
Michael R. Murphy
 
 
 
 
STATE OF ILLINOIS
)
 
) SS.
COUNTY OF COOK
)
 
I, Kareema M. Cruz, a Notary Public in and for the County of Cook, State of Illinois, DO HEREBY CERTIFY that Michael R. Murphy, who is personally known to me to be the same person whose name is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he signed and delivered the said instrument as his own free and voluntary act, for the uses and purposes therein set forth.
 
Given under my hand and notarial seal, this 28th day of April, 2008.
 
 
/s/ Kareema M. Cruz
 
 
Notary Public
 
-----END PRIVACY-ENHANCED MESSAGE-----